Taken together, our study provides evidence to support a role of lncRNA SNHG6-miR101 axis in tamoxifen resistance of ER-positive breast cancers which involves modulation of EMT and cancer stem cells phenotype through targeting of ZEB1/EZH2. This evidence concerns the gene EZH2 and cancer.